Prof. Raffaele Falsaperla, Ferrara University, Italy
Dr. Raffaele Falsaperla is a renowned pediatric neurologist and neonatologist with extensive experience in pediatric emergency care, neonatal resuscitation, and epilepsy research. He has played a vital role in advancing pediatric healthcare through clinical practice, research, and education. His leadership in numerous international research projects and affiliations with top medical institutions highlights his commitment to improving child health outcomes. As an educator, he has mentored countless medical students and professionals, shaping the future of pediatric medicine.
Education:
Raffaele Falsaperla obtained his Doctor of Medicine degree from the University of Catania in 1989, graduating with honors. He pursued a specialization in Pediatrics at the same institution, earning his postgraduate diploma in 1994, also with honors. He later completed a Ph.D. in Pediatric Sciences at the University of Catania in 1999, focusing on congenital muscular dystrophies. Further advancing his expertise, he undertook research fellowships in neuromuscular research and neuropathology at TUFTS University, Boston, in 1995 and 1997, respectively. His academic journey also includes advanced training in neonatal neurology and epilepsy through a research project at the University of Alberta, Canada, from 2019 to 2022
Professional Profiles:
ORCID Profile
Scopus Profile
Professional Experience:
With a distinguished career spanning over three decades, Dr. Falsaperla has held various prestigious positions in pediatric medicine. Since 2008, he has been the Director of the Operational Unit of Complex Pediatrics and Pediatric Emergency at AOU Policlinico, Vittorio Emanuele, Catania. He previously served as Medical Executive in Pediatric Neurology and Neonatology at different institutions. Additionally, he has been a lecturer and tutor at multiple universities, including the University of Catania, University of Messina, and University of Palermo, teaching neonatal and pediatric neurology, intensive care, and emergency medicine.
Research Interests:
Dr. Falsaperla’s research is centered on pediatric neurology, neonatal epilepsy, and neonatal resuscitation. His work explores neurophysiological disorders, neonatal seizures, and pediatric intensive care, with significant contributions to epilepsy research and the management of neurological emergencies in newborns. His involvement in multiple national and international studies underscores his commitment to advancing medical knowledge, particularly in neonatal neuroprotection and pediatric neurological disorders.
Top Notable Publications:
Cerebral White Matter Lesions and Dysmorphisms: Signs Suggestive of 6p25 Deletion Syndrome-Literature Review
Journal of Pediatric Genetics, 2019
DOI: 10.1055/s-0039-1694015
NF1 Microdeletion Syndrome: Case Report of Two New Patients
The Italian Journal of Pediatrics, 2019
DOI: 10.1186/s13052-019-0718-7
Molecular Mechanisms Involved in the Pathogenesis of Early-Onset Epileptic Encephalopathy
Frontiers in Molecular Neuroscience, 2019
DOI: 10.3389/fnmol.2019.00118
Pyridoxine Add-On Treatment for the Control of Behavioral Adverse Effects Induced by Levetiracetam in Children
The Annals of Pharmacotherapy, 2018
DOI: 10.1177/1060028018759637
Idiopathic Intracranial Hypertension in a Pediatric Population: A Retrospective Observational Study
Journal of Biological Regulators & Homeostatic Agents, 2017
Benign and Severe Early-Life Seizures: A Round in the First Year of Life
The Italian Journal of Pediatrics, 2018
DOI: 10.1186/s13052-018-0491-z
PRRT2 Gene Variant in a Child with Dysmorphic Features, Congenital Microcephaly, and Severe Epileptic Seizures
The Italian Journal of Pediatrics, 2019
DOI: 10.1186/s13052-019-0755-2
Microcephaly/Trigonocephaly, Intellectual Disability, Autism Spectrum Disorder, and Atypical Dysmorphic Features in a Boy with Xp22.31 Duplication
Molecular Syndromology, 2019
DOI: 10.1159/000493174
GLUT-1DS Resistant to Ketogenic Diet: From Clinical Feature to In Silico Analysis
Neurogenetics, 2024
DOI: 10.1007/s10048-023-00742-8
Molecular Dynamic Simulations to Determine Individualized Therapy: Tetrabenazine for the GNAO1 Encephalopathy E246K Variant
Molecular Diagnosis & Therapy, 2024
DOI: 10.1007/s40291-024-00706-0
Conclusion: